Up-regulation of μ-opioid receptor-mediated G-protein activation in protein kinase Cγ knockout mice following repeated naloxone treatment

Neuroscience Letters

Volumn 338, Issue 2, 2003, Pages 103-106

  Narita, Minoru ^a   Suzuki, Masami ^a   Mizoguchi, Hirokazu ^b,c   Narita, Michiko ^a   Yajima, Yoshinori ^a   Sakurada, Shinobu ^c   Tseng, Leon F ^b   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

G protein; Naloxone; Protein kinase C; Up regulation; Opioid receptor

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ISOENZYME; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; PROTEIN KINASE C; PROTEIN KINASE C GAMMA; UNCLASSIFIED DRUG;

ENZYME BINDING; IMMUNOREACTIVITY; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SPINAL CORD;

EID: 0037468310     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01354-X     Document Type: Review

References (15)

1. Abeliovich A., Chen C., Goda Y., Sliva A.J., Stevens C.F., Tonegawa S. Modified hippocampal long-term potentiation in PKCγ-mutant mice. Cell. 75:1993;1253-1262.
2. 5- enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat. Gen. Pharmacol. 24:1993;1351-1357.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
4. Castelli M.P., Melis M., Mameli M., Fadda P., Diaz G., Gessa G.L. Chronic morphine and naltrexone fail to modify mμ-opioid receptor mRNA levels in the rat brain. Mol. Brain Res. 45:1997;149-153.
5. Chen Y., Mestek A., Liu J., Hurley A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
6. Duttaroy A., Shen J., Shah S., Chen B., Sehba F., Carroll J., Yoburn B.C. Opioid receptor upregulation in μ-opioid receptor deficient CXBK and outbred Swiss Webster mice. Life Sci. 65:1999;113-123.
7. Lee S.C., Yoburn B.C. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity. Pharmacol. Biochem. Behav. 66:2000;347-351.
8. Mao J., Price D.D., Phillips L.L., Lu J., Mayer D.J. Increases in protein kinase Cγ immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677:1995;257-267.
9. Narita M., Mizoguchi H., Nagase H., Suzuki T., Tseng L.F. Up-regulation of spinal μ-opioid receptor function to activate G-protein by chronic naloxone treatment. Brain Res. 913:2001;170-173.
10. 5]enkephalin. J. Neurosci. 21:2001;3715-3720.
11. Narita M., Mizoguchi H., Suzuki T., Narita M., Dun N.J., Imai S., Yajima Y., Nagase H., Suzuki T., Tseng L.F. Enhanced μ-opioid responses in the spinal cord of mice lacking protein kinase Cγ isoform. J. Biol. Chem. 276:2001;15409-15414.
12. Shah S., Duttaroy A., Chen B.T., Carroll J., Yoburn B.C. The effect of μ-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation. Brain Res. Bull. 42:1997;479-484.
13. Unterwald E.M., Rubenfeld J.M., Imai Y., Wang J.B., Uhl G.R., Kreek M.J. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Mol. Brain Res. 33:1995;351-355.
14. Way K.J., Chou E., Kng G.L. Identification of PKC isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21:2000;181-187.
15. Yoburn B.C., Shah S., Chan K., Duttaroy A., Davis T. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity. Pharmacol. Biochem. Behav. 51:1995;535-539.